Xylazine: An emerging threat in obstetrics.

J Obstet Gynaecol Can

Department of Family and Community Medicine, Western Michigan University.

Published: January 2025

Xylazine, an alpha-adrenergic agent, is a common adulterant in the non-prescribed opioid supply. It has multiplicative sedative effects when used with opioids and these effects can negatively impact pregnancy. Given that the opioid epidemic in Canada is not abating and continues to evolve, cases of xylazine exposure during pregnancy are beginning to present in obstetrical units and emergency departments. Rapid dissemination regarding the obstetrical and medical complications that may be seen in patients presenting with unstable opioid use disorders is needed.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jogc.2025.102773DOI Listing

Publication Analysis

Top Keywords

xylazine emerging
4
emerging threat
4
threat obstetrics
4
obstetrics xylazine
4
xylazine alpha-adrenergic
4
alpha-adrenergic agent
4
agent common
4
common adulterant
4
adulterant non-prescribed
4
non-prescribed opioid
4

Similar Publications

Xylazine: An emerging threat in obstetrics.

J Obstet Gynaecol Can

January 2025

Department of Family and Community Medicine, Western Michigan University.

Xylazine, an alpha-adrenergic agent, is a common adulterant in the non-prescribed opioid supply. It has multiplicative sedative effects when used with opioids and these effects can negatively impact pregnancy. Given that the opioid epidemic in Canada is not abating and continues to evolve, cases of xylazine exposure during pregnancy are beginning to present in obstetrical units and emergency departments.

View Article and Find Full Text PDF

Introduction: As illicit drug manufacturers find new ways to market their products and increase their profit margins, multiple contaminants have found their way into the illicit drug supply. The newest addition, xylazine, also known as "tranq," has spread through the city of Philadelphia and has recently been gaining ground across the United States, including in the state of Florida.

Case Presentation: This case describes a 37-year-old male with a significant past psychiatric history of severe polysubstance intravenous (IV) use, including fentanyl and methamphetamine.

View Article and Find Full Text PDF

Street Pharmacology: Toxico-Dermatology of Injection Drug Use.

J Clin Pharmacol

January 2025

Division of Dermatology, Norton College of Medicine, SUNY Upstate Medical University, Syracuse, NY, USA.

Street medicine is a point-of-care, mobile approach that services the needs of unhoused individuals who are otherwise unable to access medical care in traditional settings. The prevalence of injection drug use combines with the pipeline of illicit substances, to produce a constellation of severe, potentially life-threatening dermatological disorders unique to this population. This review applies principles of clinical pharmacology to clarify the mechanisms underlying the dermatological toxicity of xylazine, desomorphine, and 3,4-methylenedioxymethamphetamine (MDMA).

View Article and Find Full Text PDF

Background: The increasing use of social media to share lived and living experiences of substance use presents a unique opportunity to obtain information on side effects, use patterns, and opinions on novel psychoactive substances. However, due to the large volume of data, obtaining useful insights through natural language processing technologies such as large language models is challenging.

Objective: This paper aims to develop a retrieval-augmented generation (RAG) architecture for medical question answering pertaining to clinicians' queries on emerging issues associated with health-related topics, using user-generated medical information on social media.

View Article and Find Full Text PDF

Background: The rise in xylazine-adulterated heroin and fentanyl poses novel challenges to hand surgeons and a rising epidemic of necrotic upper-extremity wounds. While prior case studies have focused on particularly severe and complex xylazine-associated necrotic (XAN) wounds, the aim of this consecutive case series was to characterize the variability of presentations (ranging from mild to severe) at a single institution at the epicenter of the xylazine epidemic.

Methods: Patients presenting to a tertiary referral center for XAN upper-extremity wounds were retrospectively identified from emergency department visits and hospital admissions between January 2021 and December 2023.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!